  | PERCHOUX, C., TOPALIAN, N., Klein, S., Chaix, B., Tharrey, M., Röcke, C., GERBER, P., KLEIN, O., Missling, A., OMRANI, H., Helbich, M., Van Dyck, D., Kestens, Y., DIJST, M., & FAGHERAZZI, G. (02 September 2025). Geographic environments, daily activities and stress in Luxembourg (the FragMent study): a protocol combining map-based questionnaires, geographically explicit ecological momentary assessment and vocal biomarkers of stress. BMJ Open, 15 (9), 105499. doi:10.1136/bmjopen-2025-105499  Peer Reviewed verified by ORBi |
 | TOPALIAN, N., FAGHERAZZI, G., & PERCHOUX, C. (27 June 2025). Daily mobility, activity and environmental determinants of stress in ecological momentary assessment (EMA) and GPS studies: a scoping review protocol. BMJ Open, 15 (6), 091509. doi:10.1136/bmjopen-2024-091509 Peer Reviewed verified by ORBi |
 | Fischer, A., Zhang, L., Elbéji, A., WILMES, P., Snoeck, C. J., Larché, J., Oustric, P., OLLERT, M., & FAGHERAZZI, G. (25 April 2025). Trajectories of persisting Covid- 19 symptoms up to 24 months after acute infection: findings from the Predi-Covid cohort study. BMC Infectious Diseases, 25 (1), 603. doi:10.1186/s12879-025-11023-0 Peer Reviewed verified by ORBi |
 | Vausort, M., Lumley, A. I., Boubakeur, H., Zhang, L., Hefeng, F. Q., OLLERT, M., WILMES, P., FAGHERAZZI, G., & DEVAUX, Y. (March 2025). Association of LEF1-AS1 with cardiovascular and neurological complications of COVID-19. Journal of Molecular and Cellular Cardiology Plus, 11, 100280. doi:10.1016/j.jmccpl.2024.100280 Peer Reviewed verified by ORBi |
 | Fischer, A., Aguayo, G., Pinker, I., Oustric, P., Lachaise, T., WILMES, P., Larché, J., Benoy, C., & FAGHERAZZI, G. (09 September 2024). Co-design of a voice-based app to monitor long COVID symptoms with its end-users: A mixed-method study. Digital Health, 10, 20552076241272671. doi:10.1177/20552076241272671 Peer Reviewed verified by ORBi |
 | KLEE, M., AHO, V., MAY, P., Heintz-Buschart, A., LANDOULSI, Z., JONSDOTTIR, S., PAULY, C., PAVELKA, L., DELACOUR, L., KAYSEN, A., Krüger, R., WILMES, P., LEIST, A., Acharya, G., Aguayo, G., Alexandre, M., ALI, M., Ammerlann, W., ARENA, G., ... ZELIMKHANOV, G. (2024). Education as Risk Factor of Mild Cognitive Impairment: The Link to the Gut Microbiome. Journal of Prevention of Alzheimer's Disease. doi:10.14283/jpad.2024.19 Peer Reviewed verified by ORBi |
 | Santos da Silva, E., Servais, J.-Y., Kohnen, M., Arendt, V., Staub, T., The Con-Vince Consortium, The CoVaLux Consortium, Krüger, R., FAGHERAZZI, G., WILMES, P., Hübschen, J. M., OLLERT, M., Perez-Bercoff, D., & Seguin-Devaux, C. (06 October 2023). Validation of a SARS-CoV-2 Surrogate Neutralization Test Detecting Neutralizing Antibodies against the Major Variants of Concern. International Journal of Molecular Sciences, 24 (19), 14965. doi:10.3390/ijms241914965 Peer Reviewed verified by ORBi |
 | de Nies, L., Galata, V., Martin-Gallausiaux, C., DESPOTOVIC, M., BUSI, S. B., Snoeck, C. J., DELACOUR, L., Budagavi, D. P., LACZNY, C. C., HABIER, J., Lupu, P.-C., HALDER, R., Fritz, J. V., MARQUES, T., Sandt, E., O'Sullivan, M. P., GHOSH, S., SATAGOPAM, V., Consortium, C.-V., ... WILMES, P. (09 March 2023). Altered infective competence of the human gut microbiome in COVID-19. Microbiome, 11 (1), 46. doi:10.1186/s40168-023-01472-7 Peer Reviewed verified by ORBi |
 | Fischer, A., Badier, N., Zhang, L., ELBEJI, A., WILMES, P., Oustric, P., Benoy, C., OLLERT, M., & FAGHERAZZI, G. (30 November 2022). Long COVID Classification: Findings from a Clustering Analysis in the Predi-COVID Cohort Study. International Journal of Environmental Research and Public Health, 19 (23), 16018. doi:10.3390/ijerph192316018 Peer Reviewed verified by ORBi |
 | BOUR, C. G. L. A., Ahne, A., Aguayo, G., Fischer, A., Marcic, D., Kayser, P., & FAGHERAZZI, G. (October 2022). Global diabetes burden: analysis of regional differences to improve diabetes care. BMJ Open Diabetes Research and Care, 10 (5), 003040. doi:10.1136/bmjdrc-2022-003040 Peer Reviewed verified by ORBi |
 | Fischer, A., Zhang, L., ELBEJI, A., WILMES, P., Oustric, P., Staub, T., Nazarov, P. V., OLLERT, M., & FAGHERAZZI, G. (August 2022). Long COVID Symptomatology After 12 Months and Its Impact on Quality of Life According to Initial Coronavirus Disease 2019 Disease Severity. Open Forum Infectious Diseases, 9 (8), 397. doi:10.1093/ofid/ofac397 Peer Reviewed verified by ORBi |
  | Capelle, C. M., Ciré, S., Domingues, O., ERNENS, I., Hedin, F., Fischer, A., Snoeck, C. J., Ammerlaan, W., Konstantinou, M., GRZYB, K., SKUPIN, A., Carty, C. L., HILGER, C., Gilson, G., Celebic, A., WILMES, P., Del Sol, A., Kaplan, I. M., BETSOU, F., ... HE, F. (2022). Combinatorial analysis reveals highly coordinated early-stage immune reactions that predict later antiviral immunity in mild COVID-19 patients. Cell Reports Medicine, 3 (4), 100600. doi:10.1016/j.xcrm.2022.100600 Peer reviewed |
 | GOETZINGER, C. J., Alleaume, C., Schritz, A., Vrijens, B., Préau, M., FAGHERAZZI, G., & HUIART, L. (2022). Analysing breast cancer survivors' acceptance profiles for using an electronic pillbox connected to a smartphone application using Seintinelles, a French community-based research tool. Frontiers in Pharmacology, 13, 889695. doi:10.3389/fphar.2022.889695 Peer Reviewed verified by ORBi Dataset: 10.3389/fphar.2022.889695 |
 | Linn, N., GOETZINGER, C. J., Regnaux, J.-P., Schmitz, S., Dessenne, C., FAGHERAZZI, G., & Aguayo, G. A. (September 2021). Digital Health Interventions among People Living with Frailty: A Scoping Review. Journal of the American Medical Directors Association, 22 (9), 1802 - 1812.e21. doi:10.1016/j.jamda.2021.04.012 Peer Reviewed verified by ORBi Dataset: 10.1016/j.jamda.2021.04.012 |
 | BOUR, C. G. L. A., Ahne, A., Schmitz, S., PERCHOUX, C., Dessenne, C., & FAGHERAZZI, G. (27 May 2021). The Use of Social Media for Health Research Purposes: Scoping Review. Journal of Medical Internet Research, 23 (5), 25736. doi:10.2196/25736 Peer Reviewed verified by ORBi |
 | FAGHERAZZI, G., Fischer, A., Ismael, M., & DESPOTOVIC, V. (April 2021). Voice for Health: The Use of Vocal Biomarkers from Research to Clinical Practice. Digital Biomarkers, 5 (1), 78-88. doi:10.1159/000515346 Peer Reviewed verified by ORBi |
 | WILMES, P., ZIMMER, J., Schulz, J., Glod, F., Veiber, L., MOMBAERTS, L., Rodrigues, B., AALTO, A., Pastore, J., Snoeck, C. J., OLLERT, M., FAGHERAZZI, G., MOSSONG, J., GONCALVES, J., SKUPIN, A., & NEHRBASS, U. (2021). SARS-CoV-2 transmission risk from asymptomatic carriers: Results from a mass screening programme in Luxembourg. The Lancet Regional Health. Europe, 4, 100056. doi:10.1016/j.lanepe.2021.100056 Peer Reviewed verified by ORBi |